References
- Yasui T, Matsui S, Tani A, et al. Androgen in postmenopausal women. J Med Invest 2012;59:12–27
- Markopoulos MC, Kassi E, Alexandraki KI, et al. Hyperandrogenism after menopause. Eur J Endocrinol 2015;172:R79–91
- Rothman MS, Wierman ME. How should postmenopausal androgen excess be evaluated? Clin Endocrinol 2011;75:160–4
- Pasquali R, Gambineri A. Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. Eur J Endocrinol 2013;170:R75–90
- Shah D, Bansal S. Polycystic ovaries-beyond menopause. Climacteric 2014;17:109–15
- Atmaca M, Seven I, Ucler R, et al. An interesting cause of hyperandrogenemic hirsutism. Case Rep Endocrinol 2014;987272:16
- Sahmay S, Tuten A, Gurleyen H, et al. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation. Minerva Endocrinol 2014;39:215–22
- von Krogh K, Harjen H, Almas C, et al. The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells. Epilepsia 2010;51:2280–8
- Beksac S, Selcuk I, Boyraz G, et al. Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: presentation of two cases. J Turk Ger Gynecol Assoc 2013;14:182–5
- Varma T, Panchani R, Goyal A, Maskey R. A case of androgen-secreting adrenal carcinoma with non-classical congenital adrenal hyperplasia. Indian J Endocrinol Metab 2013;17 (Suppl 1):S243–5
- Singh P, Deleon F, Anderson R. Steroid cell ovarian neoplasm, not otherwise specified: a case report and review of the literature. Case Rep Obstet Gynecol 2012;2012:253152
- Chung DH, Lee SH, Lee KB. A case of ovarian steroid cell tumor, not otherwise specified, treated with surgery and gonadotropin releasing hormone agonist. J Menopausal Med 2014;20:39–42
- Alpanes M, Gonzalez-Casbas JM, Sanchez J, et al. Management of postmenopausal virilization. J Clin Endocrinol Metab 2012;97:2584–8
- Wan J, Chen X, Li X. Ovarian steroid cell tumor, not otherwise specified: a rare case of postmenopausal vaginal bleeding. Oncol Lett 2014;8:1187–9
- Kozan P, Chalasani S, Handelsman DJ, et al. A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism. J Clin Endocrinol Metab 2014;99:12–17
- Di Giacinto P, Chioma L, Vancieri G, et al. Virilizing Leydig–Sertoli cell ovarian tumor associated with endometrioid carcinoma of the endometrium in a postmenopausal patient: case report and general considerations. Clin Med Insights Case Rep 2012;5:149–53
- Sanz OA, Martinez PR, Guarch RT, et al. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient. Maturitas 2007;57:214–16
- Gheorghisan-Galateanu A, Fica S, Terzea DC, et al. Sertoli–Leydig cell tumor-a rare androgen secreting ovarian tumor in postmenopausal women. Case report and review of literature. J Cell Mol Med 2003;7:461–71
- Cserepes E, Szucs N, Patkos P, et al. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism. Gynecol Endocrinol 2002;16:213–16
- Souto SB, Baptista PV, Braga DC, Carvalho D. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism. Arq Bras Endocrinol Metabol 2014;58:68–75
- Moghazy D, Sharan C, Nair M, et al. Sertoli–Leydig cell tumor with unique nail findings in a post-menopausal woman: a case report and literature review. J Ovarian Res 2014;7:83
- Kim YT, Kim SW, Yoon BS, et al. An ovarian steroid cell tumor causing virilization and massive ascites. Yonsei Med J 2007;48:142–6